In a First, Rare Blood Clot Case Linked To Moderna Vaccine R
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
According to the case report, a man visited the hospital 10 days after he received his second dose of the Moderna coronavirus vaccine. It is unknown when the 65-year-old received the vaccine. He had been experiencing headaches on and off, had one week of pain in both of his legs and had trouble breathing for the last two days.

The man had two chronic underlying conditions: high blood pressure and hyperlipidemia, which occurs when there are high levels of fat particles in the blood. He was soon diagnosed with a condition known as thrombosis with thrombocytopenia syndrome (TTS). Specifically, the man had deep vein thrombosis (DVT) occurs when a clot forms deep in the body such as in the thigh or lower leg.

It is rare to occur in combination with low levels of blood platelets, also known as thrombocytopenia. Doctors tried to identify any other causes behind TTS including COVID-19 infection, other viruses, or thrombotic thrombocytopenic purpura, which is a rare disorder that caused blood clots to from throughout the body.

When all other options were ruled out, it lead the investigators to conclude that the blood clots were induced by the vaccine. Three days into his hospital stay, the man developed cerebral venous sinus thrombosis (CVST), a rare type of blood clot that blocks the brain's sinus channels of draining blood, which can cause hemorrhages.

Doctors said that the man died 12 days later despite 'rapid and exhaustive' treatment including an inferior vena cava filter that traps large clot fragments and medication such as as bivalirudin.

'The authors note that COVID-19 vaccines that use mRNA technology are proven safe and effective and have been used with no such events in millions of people,' the release states. 'They conclude that such a rare event, even if confirmed by additional reports, should not prevent persons from receiving the benefits of these vaccines.'

Source:
https://www.acpjournals.org/doi/10.7326/l21-0244
Dr. T●●●●z H●●●●●●i and 2 other likes this
Like
Comment
Share